Farmakokinetiske interaktionsundersøgelser hos postmenopausale kvinder har vist, at der ikke er interaktion med tamoxifen eller hormon substitutions- behandling (østrogen).
Pharmacokinetic interaction studies in postmenopausal women have demonstrated the absence of any interaction potential with tamoxifen or hormone replacement therapy (oestrogen).